http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102166292-B1
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-318 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q19-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-355 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5044 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q19-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-35 |
filingDate | 2018-11-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2020-10-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2020-10-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | KR-102166292-B1 |
titleOfInvention | Skin whitening composition comprising quinine based compounds as effective ingredients and method for screening the same compounds |
abstract | The present invention relates to a composition for skin whitening comprising a quinone compound represented by the following structural formula 1 as an active ingredient. Thereby, such a composition contains a quinone-based compound screened from a quinone-based compound library derived from a natural product, and exhibits an inhibitory effect on melanogenesis through the Wnt/β-catenin signaling pathway. It shows very excellent effects in the treatment and prevention of skin whitening and hyperpigmentation diseases. [Structural Formula 1] |
priorityDate | 2018-11-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 131.